Zobrazeno 1 - 2
of 2
pro vyhledávání: '"G. Caleb Alexander"'
Autor:
G. Caleb Alexander, Bruce Ovbiagele, Aaron S. Kesselheim, Scott S. Emerson, David S. Knopman, Richard J. Kryscio, Joel S. Perlmutter
Publikováno v:
New England Journal of Medicine. 385:769-771
Revisiting FDA Approval of Aducanumab Given the scientific, regulatory, and clinical implications of the accelerated FDA approval of aducanumab for Alzheimer’s disease, it’s essential to consider b...
Autor:
Victor M. Montori, Cynthia A. Jackevicius, G. Caleb Alexander, Karen Tu, Harlan M. Krumholz, Nilay Shah
Publikováno v:
New England Journal of Medicine. 363:2081-2084
After the diabetes drug rosiglitazone was linked to an increased risk of MI, the FDA issued a boxed warning for the drug. The warning led to decreases in the rate of rosiglitazone use, but some use persisted, and the level of use varied by location.